Sandra Moore

5.7k citations
11 papers · 1.8k · 1 hit paper · h-index 9

Impact in

  • Genetics top 0.5%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Lymphocytic Leukemia Research
  • Hematology top 1%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
    • Platelet Disorders and Treatments

Papers in

    • Myeloproliferative Neoplasms: Diagnosis and Treatment 6
    • Acute Myeloid Leukemia Research 3
    • Chronic Myeloid Leukemia Treatments 2

Sandra Moore

11 papers receiving 1.8k citations

Sandra Moore's Hit Papers

MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia 2006 · 1.1k citations
1.1k0+6+13Years since publication2505007501000

Peers

Sandra Moore
Comparison fields: 5 of 66
  • Genetics 1.3k
  • Hematology 1.0k
  • Rheumatology 399
  • Molecular Biology 887
  • Oncology 238
Replace Jyoti Nangalia with:
Jyoti Nangalia United Kingdom
Rachel Okabe United States
Jean‐Luc Laï France
Pierre Laneuville Canada
J V Melo United Kingdom
Kimberly Hayes United States
Gabriele Gugliotta Italy
Eva Hellström‐Lindberg Sweden
Joanna Góra‐Tybor Poland
Marjorie Boissinot United Kingdom
Sandra Moore relative to Jyoti Nangalia United Kingdom Jyoti Nangalia's profile →
Citations per field
00.5×1.5×2.0×
Jyoti Nangalia · 1×
Citations per year

Countries citing papers authored by Sandra Moore

Since Specialization
Citations

This map shows the geographic impact of Sandra Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Moore more than expected).

Fields of papers citing papers by Sandra Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Moore. The network helps show where Sandra Moore may publish in the future.

Co-authors

The 25 scholars most cited alongside Sandra Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandra Moore Line = papers co-authored together Sandra Moore links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
Hit paper breakdown →
20061071
2 2008318
3 2008108
4 200980
5 200576
6 200961
7 201558
8 201033
9 200711
10 20224
11 20041

About Sandra Moore

Sandra Moore is a scholar working on Genetics, Hematology, Molecular Biology, Rheumatology and Oncology, having authored 11 papers that have together received 1.8k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Eosinophilic Disorders and Syndromes (4 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Galectins and Cancer Biology (1 paper), Protein Degradation and Inhibitors (1 paper) and Mitochondrial Function and Pathology (1 paper). The work is most often cited by research in Genetics (1.3k citations), Hematology (1.0k citations), Rheumatology (399 citations), Molecular Biology (887 citations) and Oncology (238 citations). Sandra Moore has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Benjamin H. Lee, D. Gary Gilliland, Ross L. Levine, Thomas Mercher, Maricel Gozo, Elizabeth McDowell, Gerlinde Wernig, Yana Pikman, Daniel J. DeAngelo and Todd R. Golub. Their work appears in journals such as Blood, Cell stem cell, European Journal of Human Genetics, Oncogene and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact